180 related articles for article (PubMed ID: 29730188)
1. Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening.
Giordano A; Forte G; Massimo L; Riccio R; Bifulco G; Di Micco S
Eur J Med Chem; 2018 May; 152():253-263. PubMed ID: 29730188
[TBL] [Abstract][Full Text] [Related]
2. Forging New Scaffolds from Old: Combining Scaffold Hopping and Hierarchical Virtual Screening for Identifying Novel Bcl-2 Inhibitors.
Kanakaveti V; Rathinasamy S; Rayala SK; Gromiha M
Curr Top Med Chem; 2019; 19(13):1162-1172. PubMed ID: 31210110
[TBL] [Abstract][Full Text] [Related]
3. Panel docking of small-molecule libraries - Prospects to improve efficiency of lead compound discovery.
Sarnpitak P; Mujumdar P; Taylor P; Cross M; Coster MJ; Gorse AD; Krasavin M; Hofmann A
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):941-7. PubMed ID: 26025037
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORγ inhibitors using virtual screening, synthesis and biological evaluation.
Zhang Y; Xue X; Jin X; Song Y; Li J; Luo X; Song M; Yan W; Song H; Xu Y
Eur J Med Chem; 2014 May; 78():431-41. PubMed ID: 24704616
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors.
Leechaisit R; Pingaew R; Prachayasittikul V; Worachartcheewan A; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2019 Oct; 27(19):115040. PubMed ID: 31416738
[TBL] [Abstract][Full Text] [Related]
6. Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods.
De Vita S; Lauro G; Ruggiero D; Terracciano S; Riccio R; Bifulco G
J Chem Inf Model; 2019 Nov; 59(11):4678-4690. PubMed ID: 31593460
[TBL] [Abstract][Full Text] [Related]
7. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
8. Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors.
Zaraei SO; Sbenati RM; Alach NN; Anbar HS; El-Gamal R; Tarazi H; Shehata MK; Abdel-Maksoud MS; Oh CH; El-Gamal MI
Eur J Med Chem; 2021 Nov; 224():113674. PubMed ID: 34237622
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
[TBL] [Abstract][Full Text] [Related]
10. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
[TBL] [Abstract][Full Text] [Related]
11. Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators.
Chakka N; Andrews KL; Berry LM; Bregman H; Gunaydin H; Huang L; Guzman-Perez A; Plant MH; Simard JR; Gingras J; DiMauro EF
Eur J Med Chem; 2017 Sep; 137():63-75. PubMed ID: 28575722
[TBL] [Abstract][Full Text] [Related]
12. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule sphingomyelin synthase inhibitors.
Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
Zhang M; Zhu W; Li Y
Eur J Med Chem; 2013 Apr; 62():301-10. PubMed ID: 23376248
[TBL] [Abstract][Full Text] [Related]
15. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.
Peng K; Li Y; Bai Y; Jiang T; Sun H; Zhu Q; Xu Y
Bioorg Med Chem; 2020 Jan; 28(1):115183. PubMed ID: 31744780
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.
Zhou C; Kang D; Xu Y; Zhang L; Zha X
Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors.
Alsaid MS; Al-Mishari AA; Soliman AM; Ragab FA; Ghorab MM
Eur J Med Chem; 2017 Dec; 141():84-91. PubMed ID: 29028534
[TBL] [Abstract][Full Text] [Related]
20. Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
Zhao H; Gartenmann L; Dong J; Spiliotopoulos D; Caflisch A
Bioorg Med Chem Lett; 2014 Jun; 24(11):2493-6. PubMed ID: 24767840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
